[1] WEISSLEDER R, MAHMOOD U. Molecular imaging(Review). 2001(2)
[2] FRASER J K, SCHREIBER R, STREM B. Plasticity of human adipose stem cells toward endothelial cells and cardiomyocytes, 2006(z1)
[3] KATRITSIS D G, SOTRIOPOULOU P A, KARVOUNI E. Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium. 2005(3). doi:10.1002/ccd.20406
[4] KEIICHI F, SHINSUKE Y. Stem cells as a source of regenerative cardiomyocytes. 2006(8). doi:10.1161/01.RES.0000218272.18669.6e
[5] FREYMAN T, POLIN G, OSMAN H. A quantitative,randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. 2006(9). doi:10.1093/eurheartj/ehi818
[6] ASKARI A T, UNZEK S, POPOVIC Z B. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. 2003(9385). doi:10.1016/S0140-6736(3)14232-8
[7] WANG Y, JOHNSEN H E, MORTENSENO S. Changes in circulating mesenchymal stem cells,stem cell homing factor,and vascular growth factors in patients with acute ST elevation myocardial infarction treated with primary percutaneous coronary intervention. 2006(6). doi:10.1136/hrt.2005.069799
[8] BOYLE A J, SCHULMAN S P, HARE J M. Stem cell therapy for cardiac repair:ready for the next step. 2006(6). doi:10.1161/CIRCULATIONAHA.105.590653
[9] STRAUER B E, BREHM M, ZEUS T. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. 2002(15). doi:10.1161/01.CIR.0000034046.87607.1C
[10] ASSMUS B, SCHACHINGER V, TEUPE C. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction(TOPCARE-AMI). 2002(24). doi:10.1161/01.CIR.0000043246.74879.CD
[11] SCHACHINGER V, ASSMUS B, BRITTEN M B. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction:final one-year results of the TOPCARE-AMI Trial. 2004(8). doi:10.1016/j.jacc.2004.08.014
[12] RUCHAN A, SERKAN D, TUMER C. Regenerative medicine for cardiovascular disorders-new milestones:adult stem cells. 2006(4). doi:10.1111/j.1525-1594.2006.00209.x
[13] BULTE J W, DOUGLAS T, WITWER B. Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. 2001(12). doi:10.1038/nbt1201-1141
[14] PENNELL D J, SECHTEM U P, HIGGINS C B. Clinical indications for cardiovascularmagnetic resonance(CMR):consensus panel report. 2004(21). doi:10.1016/j.ehj.2004.06.040
[15] JAFFER F A, WEISSLEDER R. Seeing within:molecular imaging of the cardiovascular. 2004(4). doi:10.1161/01.RES.0000119321.18573.5A
[16] RUDIN M, RAUSCH M, STOECKLI M. Molecular imaging in drug discovery and development:potential and limitations of nonnuclear methods, 2005(1)
[17] BULTE J W, KRAITCHMAN D L, MACKAY A M. Chondrogenic differentiation of mesenchymal stem cells is inhibited after magnetic labeling with ferumoxides. 2004(10). doi:10.1182/blood-2004-06-2117
[18] DICK A J, GUTTMAN M A, RAMAN V K. Magnetic resonance fluoroscopy alllows targeted delivery of mesenchymal stem cells to infarct borders in swine. 2003(23). doi:10.1161/01.CIR.0000095790.28368.F9
[19] KRAITCHMAN D L, HELDMAN A W, ATLAR E. In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. 2003(18). doi:10.1161/01.CIR.0000070931.62772.4E
[20] HILL J M, DICK A J, RAMAN V K. Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells. 2003(8). doi:10.1161/01.CIR.0000084537.66419.7A
[21] BULTE J W, KOSTURA L, MACKAY A. Feridex-labeled mesenchymal stem cells:cellular differentiation and MR assessment in a canine myocardial infarction. 2005(z1). doi:10.1016/j.acra.2005.02.014
[22] BAKLANOV D V, DEMUINCK E D, THOMPSON C A. Novel double contrast MRI technique for intramyocardial detection of percutaneously transplanted autologous cells. 2004(6). doi:10.1002/mrm.20292
[23] CYRUS T, WINTER P M, CARUTHERS S D. Magnetic resonance nanoparticles for cardiovascular molecular imaging and therapy. 2005(4). doi:10.1586/14779072.3.4.705 |
